|
Primer on Medical Genomics Part X: Gene therapy
|
Gene therapy is defined as any therapeutic procedure in which genes are intentionally introduced into human somatic cells. Both preclinical and clinical gene therapy research have been progressing rapidly during the past 15 years; gene therapy is now a highly promising new modality for the treatment of numerous human disorders. Since the first clinical test of gene therapy in 1989, more than 600 gene therapy protocols have been approved, and more than 3000 patients have received gene therapy....
Related newspaper, magazine, and journal articles from HighBeam Research
|
Gene Therapy `Oversold' By Researchers, Journalists; NIH Advisers Cite Nearly Uniform Failure
The Washington Post
; ... has been "oversold" by scientists and the news media even though it has been a nearly ... just for the status they confer. Both the news media and research establishment were accused ... you get no information," Orkin said at a news briefing after the presentation to Varmus ...
|
|
|
Primer on Medical Genomics Part X: Gene therapy
Mayo Clinic Proceedings
; Gene therapy is defined as any therapeutic procedure in which genes are intentionally introduced into human somatic cells. Both preclinical and clinical gene therapy research have been progressing rapidly during the past 15 years; gene therapy is now a highly promising new modality for the
|
|
Human gene therapy: Genes without frontiers?
The American Biology Teacher
; Human gene therapy, the augmentation of a patient's genome with artificially introduced genetic material, is one of the most exciting subjects in modern biology; it captures the interest of introductory biology students due to its cutting edge nature, easily understood enormous medical potential,
|
|
Latecomer Boston labs eyeing gene therapy
The Boston Globe
; Little more than three years after physicians inserted genes from a laboratory dish into little Ashanthi DeSilva's white blood cells in an attempt to treat a lethal immune deficiency, the new science of gene therapy is rapidly gaining momentum. Hospitals everywhere are agonizing over how soon to
|
|
Guest editorial: the promise of gene therapy.(Opinion)
OB GYN News
; In recent years, research on gene therapy has yielded successes that offer much hope to patients suffering from a spectrum of diseases. I expect great advances in the coming years, but researchers still face obstacles. One sign of the field's development is the growth of related professional
|
|
Gene therapy: Are you a believer?
Biopharm
; Long-term investment in gene therapy companies holds life-saving and money-making potential Mother Nature is not perfect, and occasionally she does make mistakes. On a genetic level, her errors include sometimes giving someone a mutant copy of a gene that afflicts him or her with a disease.
|
|
GENE THERAPY:SAVIO L. C. WOO
Congressional Testimony
; 00-00-0000 TESTIMONY IN SENATOR FRIST'S SUBCOMMITTEE HEARING ON GENE THERAPY I am Savio L. C. Woo, Professor and Director at the Institute for Gene Therapy and Molecular Medicine at the Mount Sinai School of Medicine in New York, and I am currently serving as president of the American Society of
|
|
Therapeutic delivery issues in Gene Therapy, Part 2: Targeting approaches
Pharmaceutical Technology
; ... NIH Investment In Research on Gone Therapy (http://www.nih.gov/news/panelrep. html) University of North Carolina Human Gene Therapy ... Research on Gene Therapy," 7 December 1995 (http:// www.nih.gov/news/panelrep.btm). 10. F.D. Ledley, "Nonviral Gene Therapy: The Promise ...
|
|
|
Therapeutic delivery issues in gene therapy, part 2: Targeting approaches
Biopharm
; ... and Recommendation of the Panel to Assess the NIH Investments in Research on Gene Therapy," 7 December 1995, http://www.nih.gov/news/panelrep.html. (10) FD. Ledley, "Nonviral Gene Therapy: The Promise of Gene as Pharmaceutical Products," Hum. Gen. Ther. 6, 1129-11 ...
|
|
NEW INITIATIVES TO PROTECT PARTICIPANTS IN GENE THERAPY TRIALS
Regulatory Intelligence Data
; 00-00-0000 As part of ongoing efforts to ensure patient protection in gene therapy trials, the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today announced two new initiatives to further strengthen the safeguards for individuals enrolled in clinical studies for
|